LACMED
5341 S0.785 ↓
0.785 ↓
-0.010 (-1.3%)| High | 0.800 |
| Low | 0.765 |
| Open | 0.795 |
| Volume | 253,800 |
| Volume (B/S) | 48,400 / 4,900 |
| Price Bid/Ask | 0.780 / 0.790 |
| 52w | 0.750 - 1.340 |
| ROE | 14.33 |
| P/E | 18.26 |
| EPS | 4.30 |
| DPS | 0.65 |
| DY | 0.83% |
| NTA | 0.3000 |
| P/B | 2.62 |
| RPS | 34.01 |
| PSR | 2.31 |
| Market Cap | 314.0M |
| Shares (mil) | 400.00 |
| CAGR % |
3Y
-10.8%
TTM
70.1%
5Y
23.3%
TTM
35.9%
|
| RSI(14) | Neutral 38.7 |
| Stochastic(14) | Neutral 30.8 |
| Stochastic RSI(14) | Neutral 55.9 |
| Average Volume (3M) | 0 |
| Relative Volume | 0.0 |
| Financial Year | Revenue ('000) | Net ('000) | EPS | DP% | Net % | Report |
|---|---|---|---|---|---|---|
| 31 Dec, 2026 | 29,368 | 1,031 | 0.2600 | - | ||
| 31 Dec, 2025 | 106,678 | 11,863 | 3.1000 | - | View |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 09 Apr 2026 | 31 Dec 2025 | Final Dividend | 26 May 2026 | 15 Jun 2026 | 0.0065 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
今日选股|公共项目推动 Lac Med盈利料增20%
券商 :兴业投行研究投资建议 :买进闭市价 :80.5仙(截至5月25日)目标价 :1.14令吉每股收益 :8仙 (2027财年估计)本益比 :9.71倍(2027财年估计)股息收益率 :3.1%(2027财年估计)LAC Med集团( LACMED,5341,主要板医疗保健)正与多个新品牌供应商进行深入洽谈,盈利有望逐季改善,并且全年可维持约20%的业绩增长,因此我们将目标价维持在1.14令吉,意味仍有约43%上涨空间。截至目前,该公司持有总值约6亿9090万令吉标书,其中8...Chinapress -
Healthcare stocks seen to gain from billing transparency push
KUALA LUMPUR: Healthcare companies with strong cost management are expected to benefit as Malaysia moves towards more transparent hospital billing and faces rising healthcare demand from an ageing population.NST -
Binastra, Eco-Shop, Kelington lead 2026 ESG picks
RHB Investment Bank Bhd (RHB IB) has selected five companies, namely Binastra Corp Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.TheStar -
Binastra, Eco-shop, Kelington among top companies for ESG investment in 2026 - RHB IB
KUALA LUMPUR: RHB Investment Bank Bhd (RHB IB) has selected five Malaysian companies, namely Binastra Corporation Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.TheStar -
仙风道股|经常收入成长60% LAC医疗盈利看涨
LAC医疗(LACMED,5341,主板医疗保健组)专注于提供医疗设备及软体系统整合等服务,分析员认为,随着经常收入基础扩大,该公司的盈利可见度已跟着增强。乐天交易分析员在报告中说,在大马医疗旅游年2026(MYMT 2026)政策带动之下,我国的目标是到2030年将医疗旅游收入从2024年的27亿2000万令吉提升至120亿令吉,这需要业者持续扩充医院及增加医疗设备投资。“LAC医疗拥有涵盖影像、诊断及资讯通讯科技(ICT)整合等11个品牌组合,有机会成为医院资本开销与营运开销供应链直接且...Sinchew
Recent Announcements
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR GIAM TECK ENG
-
DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
-
Changes in Director's Interest (Section 219 of CA 2016) - MR CHAN YUE MUN
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR CHAN YUE MUN
-
Changes in Director's Interest (Section 219 of CA 2016) - MR LIEW YOON POH